Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives

A Wagner, B Weinberger - Frontiers in immunology, 2020 - frontiersin.org
Infectious diseases are a major cause for morbidity and mortality in the older population.
Demographic changes will lead to increasing numbers of older persons over the next …

Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond

B Weinberger - Immunity & Ageing, 2021 - Springer
Preserving good health in old age is of utmost importance to alleviate societal, economic
and health care-related challenges caused by an aging society. The prevalence and …

Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups

L Boey, E Bosmans, LB Ferreira… - Human vaccines & …, 2020 - Taylor & Francis
Upon exposure to vaccine-preventable diseases, certain individuals are at increased risk for
complications due to preexisting diseases, age or immunosuppressive treatment …

Vaccination Coverage of the Elderly in Greece: A Cross‐Sectional Nationwide Study

D Papagiannis, G Rachiotis, A Mariolis… - Canadian Journal of …, 2020 - Wiley Online Library
Vaccines are important for older adults, and the morbidity and mortality of vaccine‐
preventable diseases among older adults are high. There are limited data on vaccination …

Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: a repeated cross-sectional study of the INTEGO morbidity registry

A Janssens, B Vaes, C Abels, J Crèvecoeur… - BMC Public Health, 2023 - Springer
Abstract Background Since 2014, Belgium's Superior Health Council has recommended
pneumococcal vaccination for adults aged 19–85 years at increased risk for pneumococcal …

Reducing morbidity and mortality rates from COVID-19, influenza and pneumococcal illness in nursing homes and long-term care facilities by vaccination and …

RE Thomas - Geriatrics, 2021 - mdpi.com
The COVID-19 pandemic identifies the problems of preventing respiratory illnesses in
seniors, especially frail multimorbidity seniors in nursing homes and Long-Term Care …

Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published …

S Arya, N Norton, P Kaushik… - Human Vaccines & …, 2023 - Taylor & Francis
Despite widespread use of pneumococcal vaccines throughout Europe, the burden of
pneumococcal disease (PD) in adults is considerable. To mitigate this burden, National …

Pneumococcal pneumonia and invasive pneumococcal disease in those 65 and older: Rates of detection, risk factors, vaccine effectiveness, hospitalisation and …

RE Thomas - Geriatrics, 2021 - mdpi.com
Pneumococcal pneumonia (PP) and invasive pneumococcal disease (IPD) are important
causes of morbidity and mortality in seniors worldwide. Incidence rates and serious …

Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19

V Anton-Vazquez, R Clivillé - European Journal of Clinical Microbiology & …, 2021 - Springer
To the Editor, We would like to share our experience of a series of COVID-19 patients
coinfected with pneumococcal pneumonia in a district hospital in Barcelona. Bacterial …

Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review

S Nasreen, GB Gebretekle, M Lynch, A Kurdina… - Vaccine, 2022 - Elsevier
Background Pneumococcal disease causes substantial morbidity and mortality in older
adults. Pneumococcal polysaccharide vaccine (PPV23) is routinely recommended to reduce …